Position in CAPR
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$1,935,446
-$396,817 QoQ
Shares Held
63,666
-21.2% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OPPENHEIMER & CO INC holds $44,352,224 across 44 Biotechnology names. CAPR ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,477 | $17,366,629 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
150,133 | $4,885,327 | |
| 3 | TYRA |
Tyra Biosciences, Inc.
|
84,192 | $3,224,553 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
This page
|
63,666 | $1,935,446 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,308 | $1,923,694 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
68,116 | $1,686,552 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
|
106,924 | $1,370,765 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
100,027 | $1,193,322 |
All Filings in CAPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,935,446 | 63,666 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,332,263 | 80,813 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $976,327 | 135,413 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,613,982 | 162,536 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,226,060 | 129,195 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,438,387 | 104,231 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,040,485 | 68,408 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $260,661 | 54,646 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||